Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution

Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution

The aim of the expert council "First star duo of telmisartan and indapamide in the Russian Federation", dedicated to the introduction of a new fixed-dose combination of telmisartan and indapamide (modified-release tablets) into clinical practice was to formulate an expert opinion on the po...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. O. Konradi, F. T. Ageyev, A. S. Galyavich, Yu. A. Karpov, Zh. D. Kobalava, Yu. V. Kotovskaya, S. V. Nedogoda, A. O. Nedoshivin, O. N. Tkacheva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2025-02-01
Series:	Российский кардиологический журнал
Subjects:	hypertension telmisartan indapamide fixed-dose combination telinstar
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/6249
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01)

Therapeutic and biopharmaceutical assessment of indapamide medications
by: G. V. Ramenskaya, et al.
Published: (1970-01-01)

Pharmacokinetic and Bioequivalence Study of Telzap AM<sup>®</sup> (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis<sup>®</sup> (Telmisartan) and Norvask<sup>®</sup> (Amlodipine) in Healthy Subjects
by: V. Kubesh, et al.
Published: (2020-11-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Advantages of telmisartan pharmacotherapy in elderly patients with arterial hypertension and metabolic syndrome who have suffered an ischemic stroke
by: O. A. Osipova, et al.
Published: (2022-10-01)

Treatment of hypertension in obese patients: focus on telmisartan
by: I. E. Deneka, et al.
Published: (2018-12-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension.
by: V. I. Koshlia, et al.
Published: (2015-09-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension
by: Koshlia V.I., et al.
Published: (2016-09-01)

Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01)

Influence of additional risk factors on the antihypertensive efficacy of eprosartan and telmisartan in patients with essential hypertension
by: V. V. Syvolap, et al.
Published: (2017-12-01)

Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program
by: A. O. Konradi, et al.
Published: (2021-10-01)

Indapamide microhemodynamic effects in patients with essential arterial hypertension
by: L. N. Eliseeva, et al.
Published: (2005-06-01)

Comparative analysis of antihypertensive effects of chlorthalidone and indapamide-retard in combination with azilsartan medoxomil in patients with arterial hypertension
by: Zh. D. Kobalava, et al.
Published: (2019-07-01)

USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
by: O. M. Drapkina, et al.
Published: (2017-09-01)

CLINICAL EFFICACY OF MONOTHERAPY WITH INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION OF THE I-II DEGREES
by: E. Yu. Тourkassova, et al.
Published: (2016-01-01)

TELMISARTAN IN CARDIOVASCULAR RISK REDUCTION
by: О. D. Ostroumova, et al.
Published: (2018-02-01)

Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01)

ANTIHYPERTENSIVE EFFICACY OF VERAPAMIL PLUS INDAPAMIDE IN PATIENTS WITH METABOLIC SYNDROME
by: E. M. Idrisova, et al.
Published: (2016-01-01)

Decoding Drug Interactions: Character and Degree of Pharmacokinetic Interactions Between Telmisartan and Sorafenib or Donafenib in Rats
by: Li Y, et al.
Published: (2025-07-01)

Effects of fixed-dose indapamide/perindopril combination on arterial function in patients with hypertension and chronic kidney disease: key results of the CAMERTON program
by: Zh. D. Kobalava, et al.
Published: (2019-12-01)

Long-term indapamide retard therapy in adolescents with Stage I arterial hypertension
by: I. V. Logacheva, et al.
Published: (2011-04-01)

ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

Influence of fixed combination perindopril and indapamide on heart and vascular remodeling in hypertensive patients
by: Yu. M. Lopatin, et al.
Published: (2005-02-01)

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE
by: M. L. Maksimov, et al.
Published: (2017-08-01)

CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE
by: O. D. Ostroumova, et al.
Published: (2017-09-01)

Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension
by: S. N. Tereshchenko, et al.
Published: (2010-04-01)

Single-pill combination of indapamide and perindopril: potential of practical application
by: A. M. Kochergina, et al.
Published: (2024-04-01)

INDAPAMIDE POTENTIAL AT VARIOUS STAGES OF CARDIOVASCULAR CONTINUUM AND IN SPECIFIC CLINICAL GROUPS
by: M. N. Mamedov
Published: (2010-12-01)

The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA
by: O. D. Ostroumova, et al.
Published: (2020-05-01)

Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination
by: O. D. Ostroumova, et al.
Published: (2020-01-01)

Indapamide retard as the medication of choice in elderly patients with arterial hypertension
by: I. I. Chukaeva, et al.
Published: (2013-10-01)

The investigation of kinetics dissolution of prolonged indapamide drugs in biorelevant media
by: E. Yu. Sannikova, et al.
Published: (2013-03-01)

Key determinants of the chemo-sensitizing activity of novel Telmisartan derivatives
by: Maximilian Gebhart, et al.
Published: (2025-12-01)

Pharmacokinetic and bioequivalence study of Telzap® in comparison with Mikardis® in healthy subjects after single administrationl
by: A. L. Khokhlov, et al.
Published: (2023-01-01)

Treatment of non-small cell lung cancer using chem-bioinformatics-driven engineering of exosomal cargo-vehicle for telmisartan and pioglitazone targeted-delivery
by: Nadia M. Hamdy, et al.
Published: (2025-07-01)

New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
by: Yu. A. Karpov, et al.
Published: (2023-11-01)

How to Choose the Optimal Single-Pill Combination of the First-Line Antihypertensive Drugs? The Benefits of Amlodipine and Telmisartan Combination
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

Optimal Organ Protection and Blood Pressure Control with the Single Pill Combination Lisinopril, Amlodipine and Indapamide in Arterial Hypertension
by: S. V. Nedogoda, et al.
Published: (2020-12-01)

Clinical effectiveness of amlodipine/indapamide/perindopril fixed-dose combination in patients with metabolic disorders: results of post hoc analyzes of the TRICOLOR study
by: Yu. A. Karpov, et al.
Published: (2024-08-01)

INDAPAMIDE EFFECTS ON FREE OXYGEN RADICALS PRODUCED BY BLOOD PHAGOCYTES IN PATIENTS WITH HEART FAILURE
by: E. I. Astashkin, et al.
Published: (2012-08-01)